FDA Investigator Jeffrey P Raimondi

Jeffrey P Raimondi has inspections in 12 countries as of 27 Oct 2023. Jeffrey P Raimondi has collaborated with a combinined 6624 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
82
Last Inspection Date:
27 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Singapore, United States of America, Canada, India, France, Japan, China, Taiwan, Italy, United Kingdom of Great Britain and Northern Ireland, Czechia
Co-Investigator(s):
Ademola O Daramola, Alan L Truong, Alan P Kurtzberg, Alanna Lmussawwir Bias, Alexandra B Pitkin, Alicia M Mozzachio, Amalia C Himaya, Amalia Himaya, Amanda L Fyles, Amir Alavi, Anastasia M Shields, Andrew Le, Andy B Lee, Angela E Glenn, Angela Shepas, Anh M Lac, Anita Narula, PhD, Anita R Michael, Ann L Demarco, Anthony G Emerson, Ariel Cruz Figueroa, Arsen Karapetyan, Ashar P Parikh, Atul J Agrawal, Azza Talaat, Babajide Michael Osunsanmi, Bapu R Gaddam, Barbara J White, Barbara Janine Breithaupt, Barry Cherney, PhD, Bichsa T Nguyen, Bichsa T Tran, Binh T Nguyen, Bo Chi, PhD, Bonita S Chester, Brenda W Uratani, PhD, Brian D Rogers, Brien C Fox, Bryan A Galvez, Bryan L Mcguckin, Burnell M Henry, Carla A Norris, Carla J Lundi, Carolina D Vasquez, Carr Sharpe, Carrie A Hughes, Caryn M Everly, Caryn M Mcnab, CDR Ileana Barreto Pettit, CDR Rochelle B Young, RPh, MSA, Cecilia H Kieu, Celena Ngo, Charisse K Green, Charles M Edwards, Chelsea N Sealey, Chengjiu Hu, Cheron M Portee, Cheryl A Clausen, Chiaochun J Wang, Christina V Santos, Christopher D Washington, Christopher M Jenner, Christopher R Czajka, Christopher S Keating, Christopher T Middendorf, Cynthia Jim, CSO, Dana M Klimavicz, Daniel J Lahar, Daniel J Roberts, Daniel W Cline, Darren S Brown, Darrin E Davis, David Serrano, Davinna Ligons, PhD, Davis, Deborah A Greco, Deborah Schmiel, PhD, Debra J Fracassa, Dell S Moller, Dennis Cantellops Paite, Dennis N Hoang, Desiree C Iya, Diane Cvan Leeuwen, Diane L Raccasi, Dipesh K Shah, Djamila Harouaka, Doan T Nguyen, PharmD, Dogbeda F Mackenzie, Donna Ltartaglino Besone, Douglas A Campbell, Dr. Ralph M Bernstein, PhD, Dr. Robert C Horan, MD, Dr. S Nar Ali, PhD, Dustin M James, Edith M Gonzalez, Edwin Martinez, Edwin Melendez, Eileen A Liu, Eileen T Dupont, Elizabeth A Girard, Elizabeth Ad Girard, Ephrem Hunde, PhD, Eric S Weilage, Farhana Khan, Felix Maldonado, Frances Namuswe, PhD, Gam S Zamil, Gayle S Lawson, George J Flynn, Gerard Pde Leon, Greg K Keshishyan, Guerlain Ulysse, Gunneet Kaur, Haley H Seymour, Haley Seymour, Haroon Vohra (NMI), Hasan A Irier, PhD, Henry K Lau, Herminio C Francisco, Himanshu Gupta, PhD, Hossein Khorshidi, PhD, Hyung Yul Lee, Iris C Macinnes, Isabel Y Espinosa, Ivan E Reyes, Jacek Cieslak, PhD, Jai P Singh, Jalyn M Everly, James A Barreto, James A Lane, James B Arnett, James R Fleckenstein, Janet L Bowen, Jannifer L Degroot, Jee Chung, PhD, Jeffrey D Meng, Jeffrey M Watson, Jennifer Gogley, Jennifer L Gustavus, Jennifer L Johnson, Jennifer M Gogley, Jinnie Kokiatkulkij, Joel Welch, PhD, Joey V Quitania, Jogy George, John A Gonzales, John A Gonzalez, John R Myung, Jolanna A Norton, Jonah S Ufferfilge, Jose Acruz Gonzalez, Jose Alopez Rubet, Jose M Cayuela, Jose R Hernandez, Joseph C Yen, Joshua P Wireman, Juanita Banuelos, Juanita P Versace, Jude C Dikes, Judy C Nepsa, Julie A Rorberg, Julie A Stocklin, Jun Park, PhD, June P Page, Justin A Boyd, Ka L Wong, Kari M Johansen, Katherine E Jacobitz, Kathleen R Jones, PhD, Kathryn E Ogger, Kelley, Kellia N Hicks, Kelvin Cheung, Kelvin X Sanders, Kendra A Biddick, Kevin P Foley, Kham Phommachanh, Khoa Nathanv Tran, Kim Lthomas Cruse, Kouros Kangarli, Kristin M Abaonza, Kshitij A Patkar, Lakecha N Lewis, Lance A Finnical, Lance M De Souza, MBA, Langer, Lanita F Kelley, Lata C Mathew, PhD, Latorie S Jones, Laura Fontan, MS, Laurel A Beer, Lei Zhang, PhD, Leonard H Lavi, Lillian S Wu, Lilly O Barton, Liming Zhang, Linda F Murphy, Linda Thai, Ling Yul Liu, Lisa K Capron, LT Richard A Lyght, Lucila B Nwatu, Luis A Dasta, Luis M Burgos Medero, Madushini Dharmasena, PhD, Maida Henesian (NMI), Maotang Zhou, PhD, Marcia Britt Williams, Marcus F Yambot, Maria Cruz Fisher, Maria Gutierrez Lugo, PhD, Maria I Cruz Fisher, Maria Joselopez Barragan, PhD, Marion Michaelis, Mark C Saale, Mark E Chan, Mark W Babbitt, Marshalette O Edwards, Martin K Yan, PhD, Martin Yan, Massoud Motamed, Matthew B Casale, Matthew R Clabeaux, Maurice M Sheehan, Maxyne T Lam, Meisha R Sampson, Meisha Waters, Michael A Charles, Michael D Garcia, Michael R Goga, Michael S Call, Michael Shanks, MS, Michele L Obert, Michele Perry Williams, Michelle A Marsh, Michelle Y Clark Stuart, Mihaly S Ligmond, Mohsen Rajabi Abhari, FDA, Monica Commerford, PhD, Monica Markovski, PhD, Mra Davism, Mra Mcculloughj, Mra Narulaa, Muna Algharibeh, Muralidhara B Gavini, PhD, Nadeem I Chaudhry, Nataniel Phillips Sylvain, PhD, Nayan J Patel, Nicholas A Violand, Nicholas L Hunt, Nicholas Obiri, PhD, Nicola M Fenty Stewart, Nicole E Knowlton, Nilufer M Tampal, PhD, Nilufer M Tampalm, PhD, Omotunde O Osunsanmi, Parul M Patel, Patrick C Klotzbuecher, Patrick J Lynch, Peter E Baker, Peter S Diak, Phal K Chhun, Philip F Istafanos, DMV, MS, Phillip Angart, PhD, Prabhu P Raju, Prasad Peri, Qin Xu, Ralph H Vocque, Raymond T Oji, Reba A Gates, Rebecca Rodriguez, Reyes Candau Chacon, PhD, Richard E Needham, Richard Ledwidge (nmi), PhD, Richmond K Yip, Riley C Myers, PhD, Robert C Coleman, Robert D Tollefsen, Robert Darius, Rocio Guzman Velazquez, Roger F Zabinski, Ronald L Koller, Ronda Lebland, Rumany C Penn, PharmD, Saied A Asbagh, Sandra A Boyd, Sandra A Hughes, Sangeeta M Khurana, PhD, Santiago Gallardo Johnson, Sara H Gabel, Sarah A Hassas, Sarah Arden, Sarah E Mcmullen, Sarah Forney, Sarah Kennett, PhD, Scott B Laufenberg, Scott N Lim, Scott R Nichols, PhD, Scott T Ballard, Seneca D Toms, Shelby N Turner, Sidney B Priesmeyer, Simone E Pitts, Sixto M Mercado Rios, Sonia R Peterson, Sonya L Karsik, Sri Ramakrishnaiah Yellela, Srinivas R Chennamaneni, PhD, Sriram Susrambraham, Stacie A Woods, Stanley Au, State Agency, Stephanie A Slater, MS, Steven D Kehoe, Steven E Porter, Jr, Steven Fong, MS, PhD, Steven P Donald, Sue Lee Chan, Sundy Ven, Susan F Laska, MS, Susan P Bruederle, Susanna E Ford, Analyst, Susanne M Richardson, MSc RAC ELS, Syed N Ali, Taichun Qin, PhD, Tajah L Blackburn, Tamala P Bogan, Tamala P Magee, Tanya E Malais, Tawny L Colling, Ted L Anderson, Teresa I Navas, Terri L Dodds, Thao T Kwan, Thao Tran, Thao X Tran, Theresa Kirkham (NMI), Thomas J Arista, Thomas W Gordon, Thuy T Nguyen, LCDR, Tiara Nbrown Crosen, Tomika L Bivens, Torrance J Slayton, Tracey L Harris, Tracy Denison, PhD, Truong Xuan Nguyen (Andy), Uttaniti Limchumroon (Tom), Uttaniti Lischumroon, Vibhakar J Shah, PhD, Victoria L Palmer, Virgilio F Pacio, CSO, Virginia Carroll, PhD, Walden H Lee, Wayne D Mcgrath, Wayne E Seifert, William V Millar, Wr Bowman, Xiaohui Shen, Xiaokuang Lai, PhD, Yasamin Ameri, Yong Hu, Yumi J Hiramine, Yun Wu, PhD, Yvonne C Wilkes, Yvonne Y Wu, Zachary A Bogorad, Zachary L Stamm, Zhong Li, PhD

Jeffrey P Raimondi's Documents

Publish Date Document Type Title
March, 2017 FDA 483 Kindeva Drug Delivery L.P. - Form 483, 2017-03-06
August, 2021 FDA 483 Optum Compounding Services, LLC - Form 483, 2021-08-13
March, 2017 FDA 483 Amphastar Pharmaceuticals, Inc. - Form 483, 2017-03-31
February, 2020 FDA 483 PANACEA BIOTEC PHARMA LIMITED - Form 483, 2020-02-20
September, 2019 FDA 483 Beijing Zhangguang 101 Science & Technology Co., Ltd. - Form 483, 2019-09-27
September, 2018 FDA 483 Blue Cross Laboratories, Inc. - Form 483, 2018-09-07
March, 2022 FDA 483 Microbiology & Quality Associates, Inc. - Form 483, 2022-03-24
March, 2018 FDA 483 Thibiant International, Inc. - Form 483, 2018-03-15
June, 2017 FDA 483 BELPORT COMPANY, INC. - Form 483, 2017-06-09
July, 2022 FDA 483 KARI GRAN - Form 483, 2022-07-08
January, 2023 FDA 483 Packaging On Demand, Inc. - Form 483, 2023-01-13
September, 2022 FDA 483 NuGenTec - Form 483, 2022-09-22
October, 2016 FDA 483 Nobel Bakery, Inc. - Form 483, 2016-10-13
November, 2022 FDA 483 Boehringer Ingelheim Fremont, Inc. - Form 483, 2022-11-04
July, 2019 FDA 483 Reckitt Benckiser Healthcare India Private Limited - Form 483, 2019-07-26
November, 2018 FDA 483 Response INDUSTRIA FARMACEUTICA GALENICA SENESE SRL - Form 483R, 2018-12-07
August, 2019 FDA 483 PANACEA BIOTEC PHARMA LIMITED - Form 483, 2019-08-09
March, 2021 FDA 483 U.S. Continental Marketing, Inc. - Form 483, 2021-03-18
June, 2018 FDA 483 ASA Universal Inc. dba: Sonage - Form 483, 2018-06-19
November, 2022 FDA 483 Response Boehringer Ingelheim Fremont, Inc. - Form 483R, 2022-11-29
November, 2020 FDA 483 Allure Labs, Inc - Form 483, 2020-11-23
September, 2023 FDA 483 Samsung Biologics Co., Ltd. - Form 483, 2023-09-01
June, 2019 FDA 483 First Pharma Associates LLC dba Riverpoint Pharmacy - Form 483, 2019-06-07
February, 2020 FDA 483 Sun Pharmaceutical Industries Limited - Form 483, 2020-02-07
February, 2023 FDA 483 INDOCO REMEDIES LIMITED - Form 483, 2023-02-28
December, 2019 FDA 483 DLC Laboratories, Inc. - Form 483, 2019-12-12
March, 2021 FDA 483 Weckerle Cosmetics USA, Inc - Form 483, 2021-03-26
September, 2019 FDA 483 Zhuhai Rundu Pharmaceutical Co., Ltd. - Form 483, 2019-09-20
September, 2019 FDA 483 Zhejiang Chiral Medicine Chemicals Co., Ltd. - Form 483, 2019-09-12
June, 2021 FDA 483 CUSTOM RESEARCH LABS INC - Form 483, 2021-06-04
January, 2018 FDA 483 MBi Distributing Inc. dba MBi Nutraceuticals - Form 483, 2018-01-26
March, 2022 FDA 483 Response Microbiology & Quality Associates, Inc. - Form 483R, 2022-03-22
September, 2023 FDA 483 Alcon Singapore Manufacturing Pte. Ltd. - Form 483, 2023-09-08
July, 2018 FDA 483 Vindhya Organics Private Limited - Form 483, 2018-07-18
October, 2018 FDA 483 Sun Deep Inc. - Form 483, 2018-10-18
January, 2020 FDA 483 Intarcia Therapeutics, Inc - Form 483, 2020-01-17
July, 2020 FDA 483 UNIVERSITY OF CALIFORNIA, LOS ANGELES - Form 483, 2020-08-03
March, 2023 FDA 483 Nectar Lifesciences Limited - Form 483, 2023-03-10
June, 2021 EIR Cosmetic Enterprises Ltd - EIR, 2021-06-11
November, 2021 FDA 483 Fresh Farms LLC - Form 483, 2021-11-11
August, 2022 FDA 483 Hetero Labs Limited - Form 483, 2022-08-12
August, 2022 FDA 483 Apitoria Pharma Private Limited - Form 483, 2022-08-02
November, 2018 EIR INDUSTRIA FARMACEUTICA GALENICA SENESE SRL - EIR, 2018-11-16
August, 2019 FDA 483 OXALIS LABS - Form 483, 2019-08-02
November, 2018 FDA 483 INDUSTRIA FARMACEUTICA GALENICA SENESE SRL - Form 483, 2018-11-16
November, 2022 EIR Boehringer Ingelheim Fremont, Inc. - EIR, 2022-11-04
June, 2021 FDA 483 Cosmetic Enterprises Ltd - Form 483, 2021-06-11
March, 2017 EIR Kindeva Drug Delivery L.P. - EIR, 2017-03-06
July, 2023 FDA 483 Excelvision - Form 483, 2023-07-07
August, 2022 EIR Hetero Labs Limited - EIR, 2023-11-28
August, 2022 FDA 483 Hetero Labs Limited - Form 483, 2022-08-12
November, 2023 FDA 483 Wedgewood Connect, LLC - Form 483, 2023-11-17

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more